BDRX Stock Analysis: Buy, Sell, or Hold?
BDRX - Biodexa Pharmaceuticals plc American Depositary Shs
$3.34
0.09 (2.81%)
▲
5d:
+282.62%
30d:
+265.58%
90d:
+44.65%
WAIT
LOW Confidence
Analysis Updated: Apr 10, 2026 12:00 AM ET
Earnings: Apr 10, 2026
0d
Get Alerted When BDRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: BDRX is 118.4% above fair value ($1.53). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: BDRX is 118.4% above fair value ($1.53). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: BDRX is currently trading at $3.34, which is considered extended relative to its 30-day fair value range of $0.34 to $1.53.
Technical Outlook: Technically, BDRX is in a downtrend. Immediate support is located at $0.60, while resistance sits at $4.32.
Market Sentiment: BDRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $35.53 (+993.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDRX is in a downtrend. Immediate support is located at $0.60, while resistance sits at $4.32.
Market Sentiment: BDRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $35.53 (+993.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$0.34 -
$1.53
Company Quality Score
53/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+118.4% above fair value)
- BULLISH: Strong technical setup (60/100)
- BULLISH: Trading 993.3% below Wall St target ($35.53)
- WARNING: Recommendation downgraded due to 118.4% overvaluation
Fair Price Analysis
30-Day Fair Range
$0.34 -
$1.53
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$0.60
Resistance Level
$4.32
Current Trend
Downtrend
Technical data as of
Apr 10, 2026
Fundamental Context
Wall Street Target
$35.53
(+993.3%)
Revenue Growth (YoY)
-64.1%
Share & Embed Analysis
Last updated: April 10, 2026 3:19 PM ET
Data refreshes hourly during market hours. Next update: 4:19 PM
Data refreshes hourly during market hours. Next update: 4:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDRX showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$89 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$94 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 63 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 54 HOLD |
